Xtandi (enzalutamide) supply for hospitals & distributors
Androgen receptor inhibitor · Astellas Pharma
Xtandi (enzalutamide) is Astellas' oral androgen receptor inhibitor for prostate cancer across the castration-sensitive and castration-resistant settings. It is taken once daily as capsules or film-coated tablets.
Prescription-only medicine. No prices are published. Supply is to hospitals, distributors, pharmacies and physicians against a valid prescription or purchase order. This page is product information, not medical advice.
Product facts
Strengths and presentation
- 40 mg soft capsules
- 40 mg and 80 mg film-coated tablets
Approved indications (EMA / FDA label summary)
- Metastatic hormone-sensitive prostate cancer, with androgen deprivation therapy
- Non-metastatic castration-resistant prostate cancer at high risk of metastasis
- Metastatic castration-resistant prostate cancer (before or after docetaxel)
- High-risk biochemically recurrent non-metastatic hormone-sensitive prostate cancer (label-dependent)
Short label summary only. Approved indications differ by country and line of therapy; the national label in the destination country governs.
Storage and cold chain
- Room-temperature product — store as stated on the carton, in the original pack
- No cold chain required; shipped in tamper-evident, temperature-protected packaging
How we supply
- Original manufacturer packs only — sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
- Batch number and expiry confirmed in writing before dispatch; every pack is traceable to its batch.
- Documents with every consignment: commercial invoice, batch / CoA information from the source, and packing list.
- Tamper-evident, temperature-protected shipping; no cold chain is required for this product.
- Named-patient and special-import support: we prepare the paperwork your hospital or importer needs for the local regulator.
Procurement notes
The labelled daily dose is 160 mg — four 40 mg capsules or tablets, or two 80 mg tablets. Pack sizes differ by presentation, so please state which one your formulary uses.
Who we supply
- Hospital pharmacy and procurement departments
- Licensed pharmaceutical distributors and importers
- Oncology and haematology centres
- Treating physicians arranging named-patient supply
Markets served
United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq. Import into each country follows that country's regulator (for example MOHAP / DoH / DHA, SFDA, MoPH, Kuwait MOH, Oman MOH, NHRA) — we work with the receiving institution's import route.
Frequently asked questions
Do you supply Xtandi capsules or tablets?
Both can be sourced: 40 mg capsules and 40 mg / 80 mg tablets, depending on the source market. Availability is confirmed per enquiry.
Does Xtandi need refrigeration?
No. Xtandi is a room-temperature product stored as stated on the carton and shipped in tamper-evident, temperature-protected packaging.
Is the Xtandi you supply an original manufacturer pack?
Yes. We supply Xtandi only in the original Astellas Pharma pack, sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
Which documents come with a consignment?
Commercial invoice, batch / CoA information from the source and a packing list, with batch number and expiry for every pack. Additional documents requested by your importer can be prepared.
Do you supply the UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq?
Yes — to hospitals, distributors and licensed centres in these countries, through the import or named-patient route accepted by the destination country's regulator.
How do I get a quote for Xtandi?
Send a supply inquiry on WhatsApp with strength, quantity, country and institution. We reply with a written quote, availability and expiry; we do not publish prices on the site.
Send a supply inquiry
Tell us the product, strength, quantity, destination country and the receiving institution. We reply with availability, batch/expiry and the documentation set — and a written quote. We do not sell to the public.
Send a supply inquiryOther medicines we supply to the Gulf
- Keytruda (pembrolizumab)
- Opdivo (nivolumab)
- Enhertu (trastuzumab deruxtecan)
- Tagrisso (osimertinib)
- Darzalex (daratumumab)
- Imfinzi (durvalumab)
- Tecentriq (atezolizumab)
- Perjeta (pertuzumab)
- Kadcyla (trastuzumab emtansine)
- Lynparza (olaparib)
- Revlimid (lenalidomide)
- Imbruvica (ibrutinib)
- Venclyxto (venetoclax)
- Adcetris (brentuximab vedotin)
Sources
Reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-11-04